Back
Halozyme Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Buy
68
HALO
Halozyme Therapeutics
Last Price:
$47.82
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.55 | Sell |
| 20-day SMA: | 48.02 | Sell |
| 50-day SMA: | 50.79 | Sell |
| 200-day SMA: | 50.2 | Sell |
| 8-day EMA: | 47.52 | Buy |
| 20-day EMA: | 48.25 | Sell |
| 50-day EMA: | 50.47 | Sell |
| 200-day EMA: | 50.01 | Sell |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.02 | Sell |
| Relative Strength Index (14 RSI): | 43.89 | Sell |
| Chaikin Money Flow: | 245183 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.68 - 48.8) | Sell |
| Bollinger Bands (100): | (48.97 - 60.35) | Sell |
Halozyme Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 47.54 while HALO 8-day simple moving average is 47.55, which is a Sell signal.
-
The stock price of HALO is 47.54 while Halozyme Therapeutics 20-day SMA is 48.02, which makes it a Sell.
-
Halozyme Therapeutics 50-day simple moving average is 50.79 while HALO share price is 47.54, making it a Sell technically.
-
HALO stock price is 47.54 and Halozyme Therapeutics 200-day simple moving average is 50.20, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
68
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a BuyThe current Halozyme Therapeutics [HALO] share price is $47.54. The Score for HALO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
6B
Price in USD:
47.54
Share Volume:
308.7K
Halozyme Therapeutics 52-Week Range
52-Week High:
65.53
52-Week Low:
33.15
Buy
68
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?The Halozyme Therapeutics stock price is 47.54 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 47.54 while HALO 8-day exponential moving average is 47.52, which is a Buy signal.
-
The stock price of HALO is 47.54 while Halozyme Therapeutics 20-day EMA is 48.25, which makes it a Sell.
-
Halozyme Therapeutics 50-day exponential moving average is 50.47 while HALO share price is 47.54, making it a Sell technically.
-
HALO stock price is 47.54 and Halozyme Therapeutics 200-day simple moving average is 50.01, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and an increase next year of $0.55 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is -1.02, suggesting Halozyme Therapeutics is a Sell
-
Halozyme Therapeutics Relative Strength Index (RSI) is 43.89, which suggest Halozyme Therapeutics is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics is (46.68 - 48.8), which suggest Halozyme Therapeutics is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics is (48.97 - 60.35), which suggest Halozyme Therapeutics is a Sell
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.